Ftse Mib
34.834,30
0,95%
DAX
18.652,67
0,44%
S&P 500
5.352,96
-0,02%
NASDAQ
17.173,12
-0,09%
Bitcoin
70.772,21
-0,43%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Talaris Therapeutics Inc (TALS) Talaris Therapeutics Inc (TALS) Notizie

TALS

Talaris Therapeutics (TALS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TALS
DataOraFonteTitoloSimboloCompagnia
19/04/202422:05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TALSTalaris Therapeutics Inc
19/04/202422:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TALSTalaris Therapeutics Inc
19/04/202422:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TALSTalaris Therapeutics Inc
19/03/202422:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TALSTalaris Therapeutics Inc
19/03/202422:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TALSTalaris Therapeutics Inc
19/03/202412:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
21/11/202300:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
06/11/202322:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TALSTalaris Therapeutics Inc
30/10/202321:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
17/10/202323:47GlobeNewswire Inc.Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
10/10/202322:32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TALSTalaris Therapeutics Inc
10/10/202322:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
07/10/202302:01Dow Jones NewsStocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed MartinNASDAQ:TALSTalaris Therapeutics Inc
06/10/202323:09GlobeNewswire Inc.Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
04/10/202314:30GlobeNewswire Inc.New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris TherapeuticsNASDAQ:TALSTalaris Therapeutics Inc
15/09/202312:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TALSTalaris Therapeutics Inc
15/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TALSTalaris Therapeutics Inc
13/09/202322:28Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
14/08/202313:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TALSTalaris Therapeutics Inc
22/06/202315:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TALSTalaris Therapeutics Inc
22/06/202313:30GlobeNewswire Inc.Talaris Therapeutics and Tourmaline Bio Announce Merger AgreementNASDAQ:TALSTalaris Therapeutics Inc
15/06/202301:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TALSTalaris Therapeutics Inc
30/05/202322:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TALSTalaris Therapeutics Inc
26/05/202313:00GlobeNewswire Inc.Talaris Therapeutics Announces Leadership TransitionNASDAQ:TALSTalaris Therapeutics Inc
15/05/202322:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202322:42Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202322:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202322:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TALSTalaris Therapeutics Inc
27/04/202320:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TALSTalaris Therapeutics Inc
07/04/202322:20Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TALSTalaris Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TALS

La tua Cronologia

EU
BPEY
BPCE 1.075% 18oct2028
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network